Ledger.Open graph →
SEC Form D · Amendment · filed November 10, 2021

Proteas Bioanalytics Inc

Offering
$4.0M
Sold
$1.4M
Exemption
Rule 506(b)
Industry
Other Technology
Location
Torrance, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Spiros D. Garbis · Torrance, CAExec · DirectorDimitrios D. Iliopoulos · Glendale, CADirectorDaniel R. Mcconvey · New York, NYExec · DirectorKeith B. Hoffman · Torrance, CADirectorVanessa J. Gilman · GRAND CAYMAN, Cayman IslandsExec · DirectorKeith B. Hoffman · Torrance, CADirectorDimitrios D. Iliopoulos · Glendale, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗